文献速递肺结节与肺癌

Brock恶性风险计算器在肺癌筛查人群外的验证

Brock malignancy risk calculator for pulmonary nodules: validation outside a lung cancer screening population.
PubMed 文献 · Thorax · 2018-05-18

在荷兰两个学术中心,对2004至2012年间接受胸部CT的40岁以上患者进行巢式病例对照研究,验证Brock模型对常规临床环境中肺结节的判别性能。完整Brock模型在两个中心的AUC分别为0.90和0.91,显著高于仅基于大小的模型(0.88和0.87,p<0.001)。在10%恶性风险阈值下,敏感度为75%和81%,特异度为85%和84%,阴性预测值均为99%。

要点

  • Brock模型在非筛查临床人群中仍保持高判别力,AUC达0.90和0.91。
  • 完整Brock模型优于仅基于大小的模型,AUC差异显著(p<0.001)。
  • 10%阈值下阴性预测值达99%,可用于减少结节随访检查。

核心结论

  • Brock模型在无选择的异质性临床人群中能高预测判别良恶性结节。
  • 高阴性预测值可用于减少结节随访检查次数。

研究设计与样本

  • 通过链接国家癌症登记处确定截至2014年底的肺癌诊断,进行巢式病例对照研究(比例1:3)。
  • 两名观察者使用半自动软件标注结节,分别在各数据集上以ROC分析验证Brock模型并与仅基于大小的模型比较。

主要发现

  • 最终分析纳入中心A的177个恶性和695个良性结节,中心B的264个恶性和710个良性结节。
  • 完整Brock模型在中心A和B的AUC分别为0.90和0.91,仅大小模型分别为0.88和0.87,差异显著(p<0.001)。
  • 在10%恶性风险阈值下,完整模型敏感度为75%和81%,特异度为85%和84%,阳性预测值为14%和10%,阴性预测值为99%。
  • 中心A的最佳阈值为6%,中心B为8%,阴性预测值均>99%。

关键数值与推荐

  • 英国胸科学会建议的10%恶性风险阈值下,完整Brock模型敏感度75%和81%,特异度85%和84%,阳性预测值14%和10%,阴性预测值99%。
  • 中心A最佳阈值6%,中心B最佳阈值8%,阴性预测值均>99%。

临床怎么用

  • 在常规临床环境中可应用Brock模型评估肺结节恶性风险。
  • 利用高阴性预测值可能减少不必要的结节随访检查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the performance of the Brock malignancy risk model for pulmonary nodules detected in routine clinical setting. METHODS: In two academic centres in the Netherlands, we established a list of patients aged ≥40 years who received a chest CT scan between 2004 and 2012, resulting in 16 850 and 23 454 eligible subjects. Subsequent diagnosis of lung cancer until the end of 2014 was established through linking with the National Cancer Registry. A nested case-control study was performed (ratio 1:3). Two observers used semiautomated software to annotate the nodules. The Brock model was separately validated on each data set using ROC analysis and compared with a solely size-based model. RESULTS: After the annotation process the final analysis included 177 malignant and 695 benign nodules for centre A, and 264 malignant and 710 benign nodules for centre B. The full Brock model resulted in areas under the curve (AUCs) of 0.90 and 0.91, while the size-only model yielded significantly lower AUCs of 0.88 and 0.87, respectively (p<0.001). At 10% malignancy risk, the threshold suggested by the British Thoracic Society, sensitivity of the full model was 75% and 81%, specificity was 85% and 84%, positive predictive values were 14% and 10% at negative predictive value (NPV) of 99%. The optimal threshold was 6% for centre A and 8% for centre B, with NPVs >99%. DISCUSSION: The Brock model shows high predictive discrimination of potentially malignant and benign nodules when validated in an unselected, heterogeneous clinical population. The high NPV may be used to decrease the number of nodule follow-up examinations.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Chung K, Mets OM, Gerke PK, et al. Brock malignancy risk calculator for pulmonary nodules: validation outside a lung cancer screening population. Thorax. 2018. PMID: 29777062. doi:10.1136/thoraxjnl-2017-211372

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。